Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection
- PMID: 21193326
- DOI: 10.1016/j.healun.2010.10.009
Endothelitis in cardiac allograft biopsy specimens: possible relationship to antibody-mediated rejection
Abstract
Background: The incidence of endothelitis in cardiac transplants, and the relationship to clinical symptoms and humoral rejection, is unclear. Recently, the finding of intravascular macrophages has been found to represent antibody-mediated rejection. This study investigated the role of intravascular T lymphocytes in antibody-mediated rejection.
Methods: A total of 819 sequential biopsy specimens from 93 cardiac allograft recipients were prospectively studied. Rejection was graded according to International Society for Heart and Lung Transplantation (ISHLT) criteria and inflammatory infiltrates characterized by immunohistochemical staining for CD3, CD4, CD8, CD68, and CD20. Endothelitis was defined as lymphocyte and macrophage infiltrates within arteriolar, capillary, or venular walls, with endothelial swelling, in contrast to perivascular inflammation of cellular rejection. Complement C4d was identified in capillary walls by immunofluorescent staining and immunohistochemical staining on paraffin sections.
Results: Endothelitis was identified in 27 specimens (3%) from 14 patients (15%). ISHLT rejection grades were 0 in 6 specimens, 1R in 20 (1A in 8; 1B in 12), and 2R (3A) in 1. In all cases, there were admixtures of macrophages and T lymphocytes. Inflammation was most prominent in venules. C4d was localized in 12 of the 27 specimens (44%). C4d was localized in 31 of 796 specimens without endothelitis (p < 0.001). The endothelial infiltrates were CD3, CD4, CD8, and CD68+. Twelve of 14 patients had > 0 panel reactive antibodies (PRA), 9 were above 10%, and 8 were above 25%; 5 patients were treated for clinical antibody-mediated rejection, and 4 had possible cardiac allograft vasculopathy by ultrasound imaging (mean follow-up, 40 months).
Conclusion: Endothelitis is present in more than 10% of heart transplant recipients and is associated with complement deposition on biopsy samples. Approximately 33% of patients have clinical evidence of humoral rejection. The eventual risk for developing graft vascular disease remains undetermined.
Copyright © 2011 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Additive value of immunologic monitoring to histologic grading of heart allograft biopsy specimens: implications for therapy.J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1156-61. J Heart Lung Transplant. 1995. PMID: 8719463
-
Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.J Heart Lung Transplant. 1995 Jan-Feb;14(1 Pt 1):151-62. J Heart Lung Transplant. 1995. PMID: 7727464
-
Distinct expression of cell-cell and cell-matrix adhesion molecules on endothelial cells in human heart and lung transplants.J Heart Lung Transplant. 1995 Nov-Dec;14(6 Pt 1):1145-55. J Heart Lung Transplant. 1995. PMID: 8719462
-
Propagation and characterization of lymphocytes from transplant biopsies.Crit Rev Immunol. 1991;10(6):455-80. Crit Rev Immunol. 1991. PMID: 1830745 Review.
-
Cardiac allograft rejection.Surgeon. 2011 Jun;9(3):160-7. doi: 10.1016/j.surge.2010.11.023. Epub 2010 Dec 24. Surgeon. 2011. PMID: 21550522 Review.
Cited by
-
The perfect storm: HLA antibodies, complement, FcγRs, and endothelium in transplant rejection.Trends Mol Med. 2015 May;21(5):319-29. doi: 10.1016/j.molmed.2015.02.004. Epub 2015 Mar 20. Trends Mol Med. 2015. PMID: 25801125 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials